KAMAL PATEL M.D. NPI 1598747164

NPI Details

Kamal Patel, M.D. is a hematology and oncology internal medicine in Little Rock, AR with 40 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Kamal Patel, M.D. NPI is 1598747164. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8901 CARTI WAY
LITTLE ROCK, AR
ZIP 72205-523
Phone: (501) 219-8777
Fax: (501) 907-6522

The NPI 1598747164 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, atezolizumab, 10 mg (HCPCS:J9022)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, bendamustine hcl (bendeka), 1 mg (HCPCS:J9034)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, decitabine, 1 mg (HCPCS:J0894)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Ferritin (blood protein) level (HCPCS:82728)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Unclassified drugs (HCPCS:J3490)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Drawing of blood for a medical problem (HCPCS:99195)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Nephelometry, test method using light (HCPCS:83883)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Rheumatoid factor level (HCPCS:86431)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Vitamin d-3 level (HCPCS:82306)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Magnesium level (HCPCS:83735)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, promethazine hcl, up to 50 mg (HCPCS:J2550)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, lorazepam, 2 mg (HCPCS:J2060)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Uric acid level, blood (HCPCS:84550)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Stool analysis for blood, by peroxidase activity (HCPCS:82272)
• Folic acid level, serum (HCPCS:82746)
• Erythropoietin (protein) level (HCPCS:82668)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Blood creatinine level (HCPCS:82565)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)

The enumeration date for this NPI number is 11/18/2005 and was last updated on 3/30/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.